Patients and FVIII data
. | Children . | Adolescent/adult . |
---|---|---|
Study | Pediatric11 | Pivotal and continuation20 |
Median age, y (range) | 3.5 (1.1-6.0) | 19 (10-66) |
Median weight, kg (range) | 16 (11-27) | 68 (35-108) |
No. of subjects | 52 | 100 |
No. of PK assessments | 52 | 184 |
No. of FVIII activity data | 206 | 1829 |
Blood sampling schedule | Reduced schedule | Full schedule |
Preinfusion sample | Within 30 minutes | Immediately before |
Postinfusion samples | 1, 9, 24, and 48 hours | 15 and 30 minutes, 1, 3, 6, 9, 24, 28, 32, and 48 hours |
. | Children . | Adolescent/adult . |
---|---|---|
Study | Pediatric11 | Pivotal and continuation20 |
Median age, y (range) | 3.5 (1.1-6.0) | 19 (10-66) |
Median weight, kg (range) | 16 (11-27) | 68 (35-108) |
No. of subjects | 52 | 100 |
No. of PK assessments | 52 | 184 |
No. of FVIII activity data | 206 | 1829 |
Blood sampling schedule | Reduced schedule | Full schedule |
Preinfusion sample | Within 30 minutes | Immediately before |
Postinfusion samples | 1, 9, 24, and 48 hours | 15 and 30 minutes, 1, 3, 6, 9, 24, 28, 32, and 48 hours |